Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 13, 2007

SRI and Pentax to Advance Diagnostic Tool Development for Cancer

  • SRI International initiated a personalized medicine program to find cancer biomarkers to make diagnostic tools. This project is part of a multiyear collaboration with Pentax.

    Pentax will provide research funding and R&D milestone payments to SRI as well as royalties on sales of any resulting products.

    “Pentax and SRI are jointly addressing new opportunities in personalized medicine by developing diagnostic tools to assist in rapid and accurate selection of therapeutic options for treatment on an individual patient basis,” remarks Akira Yamamoto, research head at the Pentax Incubation Center and program director for the Pentax–SRI partnership.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »